I tend to agree- it is plausible that Novogen is being groomed for a takeover bid much to the pleasure of some and at the obvious cost to others. At this early stage, the relative expense of the clinical trials vs possible greater monetary reward would be a calculated risk worth taking for some of the larger Pharma companies. Too much smoke to suggest otherwise. Pure speculation of course & could well be wrong......only time will tell.
NRT Price at posting:
21.0¢ Sentiment: Buy Disclosure: Held
